NEW YORK (GenomeWeb) – Rosetta Genomics said today that it has received notification from the Nasdaq that it no longer meets the exchange's stockholder equity listing requirement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.